Meprofarm is primarily engaged in medicinals and botanicals activity. Its headquarters is located in Jawa Barat. The company was founded in 1973. Meprofarm, established by its founder, has grown to become a significant player in the pharmaceutical industry in Indonesia. The company focuses on the production and distribution of a wide range of pharmaceutical products, including prescription medications, over-the-counter drugs, and herbal supplements. Meprofarm's primary business line is the manufacturing of medicinals, while it also engages in the development of botanical products as a secondary line. With a strong local presence, Meprofarm operates several branches across Indonesia, ensuring its products are widely accessible throughout the country. The company is known for its commitment to quality and innovation, continuously investing in research and development to enhance its product offerings. Meprofarm's product portfolio includes well-known brands such as Meprovit, a line of vitamins and supplements, and Meprofen, a popular pain relief medication. The company has also expanded its reach beyond Indonesia, exporting its products to several countries in Southeast Asia. In terms of partnerships, Meprofarm collaborates with various local and international pharmaceutical companies to enhance its research capabilities and product distribution. The company is a member of several industry associations, which helps it stay abreast of the latest developments in the pharmaceutical sector. Meprofarm's mission is to improve the health and well-being of its customers by providing high-quality, affordable pharmaceutical products. The company envisions becoming a leading pharmaceutical manufacturer in the region, driven by innovation and a commitment to excellence.
Headquarters
RT 003 RW 004
Bandung; West Java;
Postal Code: 40294
Contact Details: Purchase the PT Meprofarm report to view the information.
Website: http://www.meprofarm.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service